Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...
Autism care software maker CentralReach has been exploring a sale, Business Insider has learned. CentralReach has tapped the investment bank William Blair to pursue a potential sale, according to ...
Investing.com -- William Blair raised DocuSign (NASDAQ:DOCU) to Outperform in a note Monday, highlighting optimism around the company’s Intelligent Agreement Management (IAM) platform and its ...
Investment analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for Tenaya Therapeutics in a research report issued to clients and investors on Monday, March 10th. William ...